Transfusion of polynitroxylated pegylated hemoglobin stabilizes pial arterial dilation and decreases infarct volume after transient middle cerebral artery occlusion

Suyi Cao, Jian Zhang, Li Ma, Carleton J.C. Hsia, Raymond C Koehler

Research output: Contribution to journalArticle

Abstract

Background--Polynitroxylation of hemoglobin confers superoxide dismutase-mimetic and peroxidase activity and may protect from reperfusion injury in addition to facilitating oxygen transport. We determined whether transfusion of polynitroxylated PEGylated hemoglobin (PNPH) is protective in the rat filament model of 2 hours of middle cerebral artery occlusion (MCAO). Methods and Results--Transfusion of 10 mL/kg of PNPH at 20 minutes of MCAO reduced infarct volume by over 70% (n=10). To determine whether PNPH might act by promoting vasodilation, pial arteriolar diameter in the distal MCA border region was measured in closed cranial windows. With no transfusion, MCAO induced an initial dilation (36±2% ±SE) that subsided by 2 hours (5±4%; n=8). With PNPH transfusion at 20 minutes of MCAO, the initial dilation (31±3%) was better maintained at 2 hours (21±4%; n=7; P < 0.02). Delaying PNPH transfusion until 90 minutes of MCAO increased perfusion in the border region from 48±6% of the preischemic baseline to 67±8% (n=8; P < 0.005). The effect of PNPH transfusion after reperfusion was also tested. Compared with the control median hemispheric infarct volume of 22% (13% to 34% interquartiles; n=15), infarct volume was reduced to 7% (3% to 13%; n=14 P < 0.05) when PNPH was transfused at 4 hours after MCAO (2 hours of reperfusion) but not significantly when transfused at 6 hours (8%; 3% to 35%; n=14) or at 8 hours (12%; 10% to 25%; n=14) after MCAO. Conclusions--PNPH transfusion has a significant therapeutic window for protection during and after transient MCAO and may act, in part, by stabilizing vascular function and improving collateral blood flow.

Original languageEnglish (US)
Article numbere006505
JournalJournal of the American Heart Association
Volume6
Issue number9
DOIs
StatePublished - Sep 1 2017

Fingerprint

Middle Cerebral Artery Infarction
Dilatation
Reperfusion
polynitroxylated pegylated hemoglobin
Reperfusion Injury
Vasodilation
Peroxidase
Superoxide Dismutase
Blood Vessels
Hemoglobins
Perfusion
Oxygen

Keywords

  • cerebral blood flow
  • Hemoglobin
  • Ischemic stroke
  • Pial vessels
  • Rats

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

@article{7bea3b38f8c14ddeb0bd05e1eae37d6d,
title = "Transfusion of polynitroxylated pegylated hemoglobin stabilizes pial arterial dilation and decreases infarct volume after transient middle cerebral artery occlusion",
abstract = "Background--Polynitroxylation of hemoglobin confers superoxide dismutase-mimetic and peroxidase activity and may protect from reperfusion injury in addition to facilitating oxygen transport. We determined whether transfusion of polynitroxylated PEGylated hemoglobin (PNPH) is protective in the rat filament model of 2 hours of middle cerebral artery occlusion (MCAO). Methods and Results--Transfusion of 10 mL/kg of PNPH at 20 minutes of MCAO reduced infarct volume by over 70{\%} (n=10). To determine whether PNPH might act by promoting vasodilation, pial arteriolar diameter in the distal MCA border region was measured in closed cranial windows. With no transfusion, MCAO induced an initial dilation (36±2{\%} ±SE) that subsided by 2 hours (5±4{\%}; n=8). With PNPH transfusion at 20 minutes of MCAO, the initial dilation (31±3{\%}) was better maintained at 2 hours (21±4{\%}; n=7; P < 0.02). Delaying PNPH transfusion until 90 minutes of MCAO increased perfusion in the border region from 48±6{\%} of the preischemic baseline to 67±8{\%} (n=8; P < 0.005). The effect of PNPH transfusion after reperfusion was also tested. Compared with the control median hemispheric infarct volume of 22{\%} (13{\%} to 34{\%} interquartiles; n=15), infarct volume was reduced to 7{\%} (3{\%} to 13{\%}; n=14 P < 0.05) when PNPH was transfused at 4 hours after MCAO (2 hours of reperfusion) but not significantly when transfused at 6 hours (8{\%}; 3{\%} to 35{\%}; n=14) or at 8 hours (12{\%}; 10{\%} to 25{\%}; n=14) after MCAO. Conclusions--PNPH transfusion has a significant therapeutic window for protection during and after transient MCAO and may act, in part, by stabilizing vascular function and improving collateral blood flow.",
keywords = "cerebral blood flow, Hemoglobin, Ischemic stroke, Pial vessels, Rats",
author = "Suyi Cao and Jian Zhang and Li Ma and Hsia, {Carleton J.C.} and Koehler, {Raymond C}",
year = "2017",
month = "9",
day = "1",
doi = "10.1161/JAHA.117.006505",
language = "English (US)",
volume = "6",
journal = "Journal of the American Heart Association",
issn = "2047-9980",
publisher = "Wiley-Blackwell",
number = "9",

}

TY - JOUR

T1 - Transfusion of polynitroxylated pegylated hemoglobin stabilizes pial arterial dilation and decreases infarct volume after transient middle cerebral artery occlusion

AU - Cao, Suyi

AU - Zhang, Jian

AU - Ma, Li

AU - Hsia, Carleton J.C.

AU - Koehler, Raymond C

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Background--Polynitroxylation of hemoglobin confers superoxide dismutase-mimetic and peroxidase activity and may protect from reperfusion injury in addition to facilitating oxygen transport. We determined whether transfusion of polynitroxylated PEGylated hemoglobin (PNPH) is protective in the rat filament model of 2 hours of middle cerebral artery occlusion (MCAO). Methods and Results--Transfusion of 10 mL/kg of PNPH at 20 minutes of MCAO reduced infarct volume by over 70% (n=10). To determine whether PNPH might act by promoting vasodilation, pial arteriolar diameter in the distal MCA border region was measured in closed cranial windows. With no transfusion, MCAO induced an initial dilation (36±2% ±SE) that subsided by 2 hours (5±4%; n=8). With PNPH transfusion at 20 minutes of MCAO, the initial dilation (31±3%) was better maintained at 2 hours (21±4%; n=7; P < 0.02). Delaying PNPH transfusion until 90 minutes of MCAO increased perfusion in the border region from 48±6% of the preischemic baseline to 67±8% (n=8; P < 0.005). The effect of PNPH transfusion after reperfusion was also tested. Compared with the control median hemispheric infarct volume of 22% (13% to 34% interquartiles; n=15), infarct volume was reduced to 7% (3% to 13%; n=14 P < 0.05) when PNPH was transfused at 4 hours after MCAO (2 hours of reperfusion) but not significantly when transfused at 6 hours (8%; 3% to 35%; n=14) or at 8 hours (12%; 10% to 25%; n=14) after MCAO. Conclusions--PNPH transfusion has a significant therapeutic window for protection during and after transient MCAO and may act, in part, by stabilizing vascular function and improving collateral blood flow.

AB - Background--Polynitroxylation of hemoglobin confers superoxide dismutase-mimetic and peroxidase activity and may protect from reperfusion injury in addition to facilitating oxygen transport. We determined whether transfusion of polynitroxylated PEGylated hemoglobin (PNPH) is protective in the rat filament model of 2 hours of middle cerebral artery occlusion (MCAO). Methods and Results--Transfusion of 10 mL/kg of PNPH at 20 minutes of MCAO reduced infarct volume by over 70% (n=10). To determine whether PNPH might act by promoting vasodilation, pial arteriolar diameter in the distal MCA border region was measured in closed cranial windows. With no transfusion, MCAO induced an initial dilation (36±2% ±SE) that subsided by 2 hours (5±4%; n=8). With PNPH transfusion at 20 minutes of MCAO, the initial dilation (31±3%) was better maintained at 2 hours (21±4%; n=7; P < 0.02). Delaying PNPH transfusion until 90 minutes of MCAO increased perfusion in the border region from 48±6% of the preischemic baseline to 67±8% (n=8; P < 0.005). The effect of PNPH transfusion after reperfusion was also tested. Compared with the control median hemispheric infarct volume of 22% (13% to 34% interquartiles; n=15), infarct volume was reduced to 7% (3% to 13%; n=14 P < 0.05) when PNPH was transfused at 4 hours after MCAO (2 hours of reperfusion) but not significantly when transfused at 6 hours (8%; 3% to 35%; n=14) or at 8 hours (12%; 10% to 25%; n=14) after MCAO. Conclusions--PNPH transfusion has a significant therapeutic window for protection during and after transient MCAO and may act, in part, by stabilizing vascular function and improving collateral blood flow.

KW - cerebral blood flow

KW - Hemoglobin

KW - Ischemic stroke

KW - Pial vessels

KW - Rats

UR - http://www.scopus.com/inward/record.url?scp=85029771903&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029771903&partnerID=8YFLogxK

U2 - 10.1161/JAHA.117.006505

DO - 10.1161/JAHA.117.006505

M3 - Article

C2 - 28899897

AN - SCOPUS:85029771903

VL - 6

JO - Journal of the American Heart Association

JF - Journal of the American Heart Association

SN - 2047-9980

IS - 9

M1 - e006505

ER -